A Study Of IMM47 In Subjects With Advanced Solid Tumors
Clinical trial NCT05985083 · UNKNOWN
Trial details
- NCT number
- NCT05985083
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2024-12-26
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.